Genome-wide Association Study identifies two novel loci for Gilles de la Tourette Syndrome

Tourette Syndrome (TS) is a childhood-onset neurodevelopmental disorder of complex genetic architecture, characterized by multiple motor tics and at least one vocal tic persisting for more than one year. We performed a genome-wide meta-analysis integrating a novel TS cohort with previously published data, resulting in a sample size of 6,133 TS individuals and 13,565 ancestry-matched controls. We identified a genome-wide significant locus on chromosome 5q15 and one array-wide significant locus on chromosome 2q24.2. Integration of eQTL, Hi-C and GWAS data implicated the NR2F1 gene and associated lncRNAs within the 5q15 locus, and the RBMS1 gene within the 2q24.2 locus. Polygenic risk scoring using previous GWAS results demonstrated statistically significant ability to predict TS status in the novel cohort. Heritability partitioning identified statistically significant enrichment in brain tissue histone marks, while polygenic risk scoring on brain volume data identified statistically significant associations with right and left putamen volumes. Our work presents novel insights in the neurobiology of TS opening up new directions for future studies.

[1]  N. Freimer,et al.  Synaptic processes and immune-related pathways implicated in Tourette syndrome , 2020, Translational Psychiatry.

[2]  X. Leinekugel,et al.  COUP-TFI/Nr2f1 Orchestrates Intrinsic Neuronal Activity during Development of the Somatosensory Cortex. , 2020, Cerebral Cortex.

[3]  Shuijin He,et al.  Imbalance of Excitatory/Inhibitory Neuron Differentiation in Neurodevelopmental Disorders with an NR2F1 Point Mutation. , 2020, Cell reports.

[4]  C. Shaw-Smith,et al.  Phenotypic expansion of Bosch–Boonstra–Schaaf optic atrophy syndrome and further evidence for genotype–phenotype correlations , 2020, American journal of medical genetics. Part A.

[5]  William J. Astle,et al.  The Polygenic and Monogenic Basis of Blood Traits and Diseases , 2020, Cell.

[6]  William J. Astle,et al.  Trans-ethnic and Ancestry-Specific Blood-Cell Genetics in 746,667 Individuals from 5 Global Populations , 2020, Cell.

[7]  Christopher D. Brown,et al.  The GTEx Consortium atlas of genetic regulatory effects across human tissues , 2019, Science.

[8]  F. Kraemer,et al.  The role of miRNAs in regulating adrenal/gonadal steroidogenesis. , 2020, Journal of molecular endocrinology.

[9]  Bing Ren,et al.  A Compendium of Promoter-Centered Long-Range Chromatin Interactions in the Human Genome , 2019, Nature Genetics.

[10]  P. Bovolenta,et al.  Mouse Nr2f1 haploinsufficiency unveils new pathological mechanisms of a human optic atrophy syndrome , 2019, EMBO molecular medicine.

[11]  Shing Wan Choi,et al.  PRSice-2: Polygenic Risk Score software for biobank-scale data , 2019, GigaScience.

[12]  H. Stefánsson,et al.  Interrogating the Genetic Determinants of Tourette's Syndrome and Other Tic Disorders Through Genome-Wide Association Studies. , 2019, The American journal of psychiatry.

[13]  Dongmei Yu,et al.  Polygenic Risk Scores Derived From a Tourette Syndrome Genome-wide Association Study Predict Presence of Tics in the Avon Longitudinal Study of Parents and Children Cohort , 2019, Biological Psychiatry.

[14]  Dajiang J. Liu,et al.  Association studies of up to 1.2 million individuals yield new insights into the genetic etiology of tobacco and alcohol use , 2018, Nature Genetics.

[15]  M. Stephens,et al.  Flexible statistical methods for estimating and testing effects in genomic studies with multiple conditions , 2016, Nature Genetics.

[16]  M. Kassem,et al.  NR2F1 mediated down-regulation of osteoblast differentiation was rescued by bone morphogenetic protein-2 (BMP-2) in human MSC. , 2018, Differentiation; research in biological diversity.

[17]  Alicia R. Martin,et al.  Discovery of the first genome-wide significant risk loci for attention deficit/hyperactivity disorder , 2018, Nature Genetics.

[18]  P. Donnelly,et al.  The UK Biobank resource with deep phenotyping and genomic data , 2018, Nature.

[19]  James T. Elder,et al.  Genetic correlations among psychiatric and immune‐related phenotypes based on genome‐wide association data , 2018, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[20]  Jeffrey D. Mandell,et al.  De Novo Sequence and Copy Number Variants Are Strongly Associated with Tourette Disorder and Implicate Cell Polarity in Pathogenesis , 2018, Cell reports.

[21]  Jonathan P. Beauchamp,et al.  Gene discovery and polygenic prediction from a genome-wide association study of educational attainment in 1.1 million individuals , 2018, Nature Genetics.

[22]  Neda Jahanshad,et al.  Concordance of genetic variation that increases risk for Tourette Syndrome and that influences its underlying neurocircuitry , 2018, bioRxiv.

[23]  P. Paschou,et al.  European Multicentre Tics in Children Studies (EMTICS): protocol for two cohort studies to assess risk factors for tic onset and exacerbation in children and adolescents , 2018, European Child & Adolescent Psychiatry.

[24]  Dan J Stein,et al.  Revealing the complex genetic architecture of obsessive–compulsive disorder using meta-analysis , 2018, Molecular Psychiatry.

[25]  M. Kanai,et al.  Genetic analysis of quantitative traits in the Japanese population links cell types to complex human diseases , 2018, Nature Genetics.

[26]  Warren W. Kretzschmar,et al.  Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression , 2017, Nature Genetics.

[27]  Nick C Fox,et al.  Analysis of shared heritability in common disorders of the brain , 2018, Science.

[28]  Erdogan Taskesen,et al.  Functional mapping and annotation of genetic associations with FUMA , 2017, Nature Communications.

[29]  Ting Wang,et al.  The 3D Genome Browser: a web-based browser for visualizing 3D genome organization and long-range chromatin interactions , 2017, Genome Biology.

[30]  Douglas W. Woods,et al.  Rare Copy Number Variants in NRXN1 and CNTN6 Increase Risk for Tourette Syndrome , 2016, Neuron.

[31]  P. Paschou,et al.  Gilles de la Tourette syndrome , 2017, Nature Reviews Disease Primers.

[32]  Christopher S. Poultney,et al.  Meta-analysis of GWAS of over 16,000 individuals with autism spectrum disorder highlights a novel locus at 10q24.32 and a significant overlap with schizophrenia , 2017, Molecular Autism.

[33]  Alan M. Kwong,et al.  Next-generation genotype imputation service and methods , 2016, Nature Genetics.

[34]  H. Stefánsson,et al.  TS-EUROTRAIN: A European-Wide Investigation and Training Network on the Etiology and Pathophysiology of Gilles de la Tourette Syndrome , 2016, Front. Neurosci..

[35]  N. Wray,et al.  Meta-analysis of genome-wide association studies of anxiety disorders , 2015, Molecular Psychiatry.

[36]  Yakir A Reshef,et al.  Partitioning heritability by functional annotation using genome-wide association summary statistics , 2015, Nature Genetics.

[37]  P. Lichtenstein,et al.  Familial Risks of Tourette Syndrome and Chronic Tic Disorders. A Population-Based Cohort Study. , 2015, JAMA psychiatry.

[38]  J. Tardif,et al.  Pharmacogenomic Determinants of the Cardiovascular Effects of Dalcetrapib , 2015, Circulation. Cardiovascular genetics.

[39]  D. Posthuma,et al.  Involvement of astrocyte metabolic coupling in Tourette syndrome pathogenesis , 2015, European Journal of Human Genetics.

[40]  A. Cavanna,et al.  Gilles de la Tourette syndrome and disruptive behavior disorders: prevalence, associations, and explanation of the relationships. , 2015, The Journal of neuropsychiatry and clinical neurosciences.

[41]  Michael Q. Zhang,et al.  Integrative analysis of 111 reference human epigenomes , 2015, Nature.

[42]  M. Tsai,et al.  COUP-TFs and eye development. , 2015, Biochimica et biophysica acta.

[43]  Yoav Ben-Shlomo,et al.  Population prevalence of Tourette syndrome: A systematic review and meta‐analysis , 2015, Movement disorders : official journal of the Movement Disorder Society.

[44]  Jack Euesden,et al.  PRSice: Polygenic Risk Score software , 2014, Bioinform..

[45]  E. Bernstein,et al.  NR2F1 controls tumor cell dormancy via SOX9 and RARβ driven quiescence programs , 2014, Nature Communications.

[46]  Carson C Chow,et al.  Second-generation PLINK: rising to the challenge of larger and richer datasets , 2014, GigaScience.

[47]  M. Daly,et al.  LD Score regression distinguishes confounding from polygenicity in genome-wide association studies , 2014, Nature Genetics.

[48]  C. Kirschbaum,et al.  The Modulating Role of Stress in the Onset and Course of Tourette’s Syndrome , 2014, Behavior modification.

[49]  Benjamin D. Greenberg,et al.  Partitioning the Heritability of Tourette Syndrome and Obsessive Compulsive Disorder Reveals Differences in Genetic Architecture , 2013, PLoS genetics.

[50]  Ellen T. Gelfand,et al.  The Genotype-Tissue Expression (GTEx) project , 2013, Nature Genetics.

[51]  J. Shimony,et al.  NR2F1 haploinsufficiency is associated with optic atrophy, dysmorphism and global developmental delay , 2013, American journal of medical genetics. Part A.

[52]  S. E. Stewart,et al.  Genome-wide association study of Tourette Syndrome , 2012, Molecular Psychiatry.

[53]  J. Leckman,et al.  Neuroendocrine aspects of Tourette syndrome. , 2013, International review of neurobiology.

[54]  I. Simon,et al.  Genome-Wide Analysis of Androgen Receptor Targets Reveals COUP-TF1 as a Novel Player in Human Prostate Cancer , 2012, PloS one.

[55]  P. Paschou,et al.  Replication of association between a SLITRK1 haplotype and Tourette Syndrome in a large sample of families , 2012, Molecular Psychiatry.

[56]  U. Nöthlings,et al.  [PopGen. A population-based biobank with prospective follow-up of a control group]. , 2012, Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz.

[57]  H. Tian,et al.  Transactivation of microRNA-383 by steroidogenic factor-1 promotes estradiol release from mouse ovarian granulosa cells by targeting RBMS1. , 2012, Molecular endocrinology.

[58]  Eleazar Eskin,et al.  Interpreting Meta-Analyses of Genome-Wide Association Studies , 2012, PLoS genetics.

[59]  Eleazar Eskin,et al.  Random-effects model aimed at discovering associations in meta-analysis of genome-wide association studies. , 2011, American journal of human genetics.

[60]  A. Bolton,et al.  Genomic and Epigenomic Instability, Fragile Sites, Schizophrenia and Autism , 2010, Current genomics.

[61]  A. Cavanna,et al.  The international prevalence, epidemiology, and clinical phenomenology of Tourette syndrome: a cross-cultural perspective. , 2009, Journal of psychosomatic research.

[62]  Richard L Robertson,et al.  NR2F1 deletion in a patient with a de novo paracentric inversion, inv(5)(q15q33.2), and syndromic deafness , 2009, American journal of medical genetics. Part A.

[63]  Carol L. Baym,et al.  Examining cortisol rhythmicity and responsivity to stress in children with Tourette syndrome , 2008, Psychoneuroendocrinology.

[64]  Manuel A. R. Ferreira,et al.  PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.

[65]  D. Reich,et al.  Population Structure and Eigenanalysis , 2006, PLoS genetics.

[66]  D. Reich,et al.  Principal components analysis corrects for stratification in genome-wide association studies , 2006, Nature Genetics.

[67]  M. Vekemans,et al.  Molecular characterisation of a prenatally diagnosed 5q15q21.3 deletion and review of the literature , 2006, Prenatal diagnosis.

[68]  M. Butler,et al.  Familial double pericentric inversion of chromosome 5 with some features of cri-du-chat syndrome , 1996, Human Genetics.

[69]  R. Holman,et al.  Vascular Factors and Risk of Dementia: Design of the Three-City Study and Baseline Characteristics of the Study Population , 2003, Neuroepidemiology.

[70]  T. Saruta,et al.  COUP-TFI expression in human adrenocortical adenomas: possible role in steroidogenesis. , 1998, The Journal of clinical endocrinology and metabolism.

[71]  B. Peterson,et al.  Steroid hormones and CNS sexual dimorphisms modulate symptom expression in tourette's syndrome , 1992, Psychoneuroendocrinology.